These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9401001)

  • 41. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1).
    Franzén A ; Heldin NE
    Biochem Biophys Res Commun; 2001 Jul; 285(3):773-81. PubMed ID: 11453659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of the cell cycle in response to inhibition of mitochondrial generated energy.
    Gemin A; Sweet S; Preston TJ; Singh G
    Biochem Biophys Res Commun; 2005 Jul; 332(4):1122-32. PubMed ID: 15925326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Lys61]N-Ras is able to induce full activation and nuclear accumulation of Cdk4 in NIH3T3 cells.
    Villalonga P; Rius E; Bachs O; Agell N
    Oncogene; 2000 Feb; 19(5):690-9. PubMed ID: 10698514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of cyclin-dependent kinase inactivation by progestins.
    Musgrove EA; Swarbrick A; Lee CS; Cornish AL; Sutherland RL
    Mol Cell Biol; 1998 Apr; 18(4):1812-25. PubMed ID: 9528753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB; Gregory FJ; Stott FJ; Hara E; Peters G
    Mol Cell Biol; 1999 Mar; 19(3):1981-9. PubMed ID: 10022885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
    Morisaki H; Ando A; Nagata Y; Pereira-Smith O; Smith JR; Ikeda K; Nakanishi M
    Exp Cell Res; 1999 Dec; 253(2):503-10. PubMed ID: 10585273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R; Laín S; Ball KL; Lane DP
    Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells.
    Teixeira C; Pratt MA
    Mol Endocrinol; 1997 Aug; 11(9):1191-202. PubMed ID: 9259311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration.
    Albrecht JH; Rieland BM; Nelsen CJ; Ahonen CL
    Am J Physiol; 1999 Dec; 277(6):G1207-16. PubMed ID: 10600818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of cyclin D1 overexpression on G1 progression-related events.
    Imoto M; Doki Y; Jiang W; Han EK; Weinstein IB
    Exp Cell Res; 1997 Oct; 236(1):173-80. PubMed ID: 9344597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1.
    Gius DR; Ezhevsky SA; Becker-Hapak M; Nagahara H; Wei MC; Dowdy SF
    Cancer Res; 1999 Jun; 59(11):2577-80. PubMed ID: 10363976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression.
    Jiang H; Chou HS; Zhu L
    Mol Cell Biol; 1998 Sep; 18(9):5284-90. PubMed ID: 9710613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice.
    Tong W; Pollard JW
    Mol Cell Biol; 1999 Mar; 19(3):2251-64. PubMed ID: 10022912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
    Stein GH; Drullinger LF; Soulard A; Dulić V
    Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence.
    Erickson S; Sangfelt O; Heyman M; Castro J; Einhorn S; Grandér D
    Oncogene; 1998 Aug; 17(5):595-602. PubMed ID: 9704925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.
    Suzuki A; Hayashida M; Ito T; Kawano H; Nakano T; Miura M; Akahane K; Shiraki K
    Oncogene; 2000 Jul; 19(29):3225-34. PubMed ID: 10918579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
    Al-Aynati MM; Radulovich N; Ho J; Tsao MS
    Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation.
    Naderi S; Gützkow KB; Christoffersen J; Smeland EB; Blomhoff HK
    Eur J Immunol; 2000 Jun; 30(6):1757-68. PubMed ID: 10898514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
    Kim DM; Yang K; Yang BS
    Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes.
    Wang W; Smith R; Safe S
    Arch Biochem Biophys; 1998 Aug; 356(2):239-48. PubMed ID: 9705214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.